← Leaderboards
Agnel Sfeir
New York University School Of Medicine
$14,727,073
Attributed
$18,360,192
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.7M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,360,192 · 9
By mechanism
R01$13,763,812 · 7
DP2$2,542,500 · 1
U01$2,053,880 · 1
Top collaborators
- Diane M Simeone5 shared
- Pascal Chartrand2 shared
- John Maciejowski1 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Gregg L Caporaso$1,054,407
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMalignant NeoplasmsIn VivoDefectMouse ModelGeneticTumorEnzymesNeoplastic CellMutationExperimental StudyCancer CellGenesPhenotypeGenomicsDna RepairBasePathway InteractionsTherapeutic TargetInsightGenomic InstabilityMutateSignal TransductionDna Damage
Grant awards (31)
Investigating Extrachromosomal DNA (ecDNA) Segregation and Repair in Cancer$3,201,530
R01 · FY2025 · CA · contact PI
Investigating the role of Microhomology-Mediated End-Joining (MMEJ) in Mitosis and its impact on drug resistance$581,381
R01 · FY2025 · CA · contact PI
Investigating the impact and dynamic of mitochondrial common deletion in somatic cells$532,067
R01 · FY2025 · AG · contact PI
Investigating telomerase dynamics in live cells at a single-molecule level$404,329
R01 · FY2025 · GM · contact PI
Investigating the impact and dynamic of mitochondrial common deletion in somatic cells$542,924
R01 · FY2024 · AG · contact PI
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma$523,841
R01 · FY2024 · CA
Investigating telomerase dynamics in live cells at a single-molecule level$404,237
R01 · FY2024 · GM · contact PI
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma$656,180
R01 · FY2023 · CA
Investigating the impact and dynamic of mitochondrial common deletion in somatic cells$542,924
R01 · FY2023 · AG · contact PI
Investigating telomerase dynamics in live cells at a single-molecule level$423,579
R01 · FY2023 · GM · contact PI
Investigating PolQ-mediated alternative NHEJ in breast cancer$379,323
R01 · FY2023 · CA · contact PI
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma$666,466
R01 · FY2022 · CA
Define the Role of POT1 Mutation in Genome Instability and Cancer$416,273
U01 · FY2022 · CA · contact PI
Investigating PolQ-mediated alternative NHEJ in breast cancer$393,372
R01 · FY2022 · CA · contact PI
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma$690,258
R01 · FY2021 · CA
Define the Role of POT1 Mutation in Genome Instability and Cancer$426,664
U01 · FY2021 · CA · contact PI
Investigating PolQ-mediated alternative NHEJ in breast cancer$224,581
R01 · FY2021 · CA · contact PI
Investigating PolQ-mediated alternative NHEJ in breast cancer$210,031
R01 · FY2021 · CA · contact PI
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma$700,147
R01 · FY2020 · CA
Investigating PolQ-mediated alternative NHEJ in breast cancer$425,096
R01 · FY2020 · CA · contact PI
Define the role of POT1 mutations in genome instability and cancer$208,643
U01 · FY2020 · CA · contact PI
Define the Role of POT1 Mutation in Genome Instability and Cancer$200,962
U01 · FY2020 · CA · contact PI
Investigating PolQ-mediated alternative NHEJ in breast cancer$418,231
R01 · FY2019 · CA · contact PI
Define the role of POT1 mutations in genome instability and cancer$394,567
U01 · FY2019 · CA · contact PI
Define the role of POT1 mutations in genome instability and cancer$406,771
U01 · FY2018 · CA · contact PI
Deciphering the extra-telomeric function of Rap1, a metabolic regulator counterac$368,663
R01 · FY2018 · DK · contact PI
Deciphering the extra-telomeric function of Rap1, a metabolic regulator counterac$368,663
R01 · FY2017 · DK · contact PI
Deciphering the extra-telomeric function of Rap1, a metabolic regulator counterac$368,663
R01 · FY2016 · DK · contact PI
Deciphering the extra-telomeric function of Rap1, a metabolic regulator counterac$368,663
R01 · FY2015 · DK · contact PI
Telomere-independent strategies to protect chromosome ends$2,542,500
DP2 · FY2014 · CA · contact PI
Deciphering the extra-telomeric function of Rap1, a metabolic regulator counterac$368,663
R01 · FY2014 · DK · contact PI